Email Updates

Search form

You are here

CTL-Mediated Immunotherapy Can Suppress SHIV Rebound in ART-Free Macaques

Include in
Published Research

Here, we evaluate the use of adoptively transferred HIV vaccine-induced subtype C Env-specific CTLs in a macaque subtype B simian-human immunodeficiency virus (SHIV) model to determine whether plasma viremia can be controlled after ART interruption. We demonstrate that adoptive cellular therapy (ACT) using autologous Env-specific T cells augmented by therapeutic vaccination can suppress ART-free viral rebound in the SHIV model.

May 21, 2019
Nature Communications